Effect of transurethral microwave thermotherapy on serum concentrations of total and free prostate-specific antigen

Scandinavian Journal of Urology and Nephrology

Volumn 31, Issue 2, 1997, Pages 173-177

  Waldén, Mauritz ^a   Dahlstrand, Christer ^a   Petersson, Silas ^a   Lindstedt, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

benign prostatic hyperplasia; prostate specific antigen; transurethral thermotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; HUMAN; HYPERTHERMIC THERAPY; MALE; MICROWAVE IRRADIATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

EID: 0031006868     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599709070325     Document Type: Article

References (24)

1. Babson AL. The Immulite automated immunoassay system. J Clin Immunoassay 1991; 14: 83-88.
2. Brawer MK, Schifman RB, Ahmann FR, Ahmann ME, Coulis KM. The effect of digital rectal examination on serum levels of prostatic-specific antigen. Arch Pathol Lab Med 1988; 112: 1110-1112.
3. Carter SSC, Patel A, Reddy P, Royer P, Ramsay JWA. Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction. J Endourol 1991; 5: 137-144.
4. Christensson A. Prostate-specific antigen. Enzyme activity and reactions with extracellular protease inhibitors (Thesis). Malmö: University of Lund, 1993.
5. Christensson A, Björk T, Nilsson O, et al. Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-105.
6. Dahlstrand C, Aldenborg F, Pettersson S. Histological findings after microwave treatment (TUMT) of benign prostatic hyperplasia (BPH). Scand J Urol Nephrol 1994; (Suppl 161), abstract No. 27.
7. Devonec M, Berger N, Perrin P. Transurethral microwave heating of the prostate - or from hyperthermia to thermotherapy. J Endourol 1991; 5: 129-135.
8. Gormley GJ. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185-1191.
9. Holmäng S, Lindstedt G, Mårin P, Hedelin H. Serum concentration of prostate-specific antigen in relation to prostate volume in 50 healthy middle-aged men. Scand J Urol Nephrol 1993; 27: 15-20.
10. Hughes HR, Penney MD, Ryan PG, Peeling WB. Serum prostatic specific antigen: in vitro stability and the effect of ultrasound rectal examination in vivo. Ann Clin Biochem 1987; 24 (Suppl S1): 206-208.
11. Leventhal EK, Rozanski TA, Morey AF, Rholl V. The effects of exercise and activity on serum prostate specific antigen levels. J Urol 1993; 150: 893-894.
12. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899-1903.
13. Lilja H. Significance of different molecular forms of serum PSA - the free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin. Urol Clin North Am 1993; 20: 681-686.
14. Lilja H, Christensson A, Dahlén U, et al. Protease-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem 1991; 37: 1618-1625.
15. Madsen PO, Iversen P. A point system for selecting operative candidates. In: Hinman F Jr, ed. Benign Prostatic Hypertrophy. New York: Springer Verlag, 1983; 763-765.
16. Oesterling JE, Jacobsen SJ, Klee GG, et al. Free, complexed and total serum prostate antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995; 154: 1090-1095.
17. Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993; 42: 276-282.
18. Romics I, Galamb L. Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients. Eur Urol 1992; 21 (Suppl 1): 83-86.
19. Simak R, Madersbacher S, Zhang Z-F, Maier U. The impact of ejaculation on serum prostate specific antigen. J Urol 1993; 150: 895-897.
20. Sinha AA, Wilson MJ, Gleason DF. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Cancer 1987; 60: 1288-1293.
21. Stamey TA, Yang N, Hay AR, Mcneal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-916.
22. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-226.
23. Strohmaier WL, Flüchter SH, Wilbert DM, Bichler KH. Influence of transrectal hyperthermia on prostate-specific antigen in prostatic cancer and benign prostatic hyperplasia. Urol Int 1993; 51: 28-31.
24. Wilcoxon L. Individual comparisons by ranking methods. Biometrics Bull 1945; 1: 80.